Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Metastatic Castration-resistant Prostate Cancer × cabazitaxel × Clear all

Phase

Status

Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7 Recurrence 2 Prostate Cancer, Hereditary, 7 1 Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Carcinoma 1 Adenocarcinoma 1

Interventions

olaparib 2 Pluvicto 2 rucaparib 1 radium Ra 223 dichloride 1 enfortumab vedotin 1 copanlisib 1 cabazitaxel 1 Radium-223 1 Nivolumab 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05340374 2025-04-06

LuCAB

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡